ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SIGHT GenSight Biologics S.A.

0.394
-0.011 (-2.72%)
May 17 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 59.23M62.21M36.98M32.48M47.36M56.65M25.94M9.13M
Total Current Assets 58.07M60.81M35.08M27.77M43.76M53.36M22.95M6.53M
Cash and Equivalents 53.98M55.45M26.24M19.25M37.94M44.29M10.61M2.13M
Total Non-Current Assets 53.34M55M23.87M10.52M11.67M15.99M-15.28M-30.7M
Total Liabilities 5.89M7.22M13.11M21.97M35.69M40.66M41.22M39.83M
Total Current Liabilities 2.9M4.1M9.6M12.09M17.12M22.24M14.64M25.29M
Total Non-Current Liabilities 2.99M3.12M3.51M19.65M34.74M30.51M42.01M20.7M
Total Equity 53.34M55M23.87M10.52M11.67M15.99M-15.28M-30.7M
Common Equity 485k606k620k821k1.02M1.16M1.16M1.63M
Retained Earnings -38.37M-24.11M-33.45M-30.87M-34.02M-28.62M-27.63M-26.22M

Your Recent History

Delayed Upgrade Clock